FGFR3 Gene

HGNC Family Receptor kinases, CD molecules (CD), Immunoglobulin superfamily domain containing
Name fibroblast growth factor receptor 3
Description This gene encodes a member of the fibroblast growth factor receptor (FGFR) family, with its amino acid sequence being highly conserved between members and among divergent species. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds acidic and basic fibroblast growth hormone and plays a role in bone development and maintenance. Mutations in this gene lead to craniosynostosis and multiple types of skeletal dysplasia. [provided by RefSeq, Aug 2017]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nFGFR3 functions as a potent oncogenic driver when aberrantly activated through chromosomal translocations and gene fusions. In glioblastoma and several epithelial cancers, fusion events—such as FGFR3–TACC3 and FGFR3–BAIAP2L1—produce chimeric proteins with constitutive tyrosine kinase activity that localize to mitotic structures, disrupt spindle organization, and provoke chromosomal segregation defects. In addition, in cancers like melanoma and lung squamous cell carcinoma, enhanced FGFR3 signaling contributes to the reactivation of downstream Ras/MAPK cascades, thereby fostering cellular transformation and even mediating acquired resistance to targeted therapies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn urothelial carcinomas, activating point mutations or over‐expression of FGFR3 are frequently observed, particularly in low‐grade papillary bladder tumors where they mark a distinct, generally favorable biological pathway. These alterations are mutually exclusive with TP53 mutations and have been exploited as diagnostic and prognostic biomarkers. Moreover, sensitive assays—including detection of circulating tumor DNA—capitalize on FGFR3 mutation status for monitoring disease recurrence, and FGFR3-targeted agents (both small-molecule inhibitors and therapeutic antibodies) have shown remarkable antitumor activity in preclinical models."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its cancer‐promoting roles, FGFR3 is central to diverse developmental processes. Germline FGFR3 mutations underlie skeletal dysplasias such as achondroplasia and thanatophoric dysplasia, as well as benign skin lesions like epidermal nevi. Its activity is intricately modulated by mechanisms including microRNA regulation, post‐endocytic trafficking, and receptor dimerization dynamics. In hematopoietic and myeloma cells, FGFR3 engages downstream effectors like p90RSK2; meanwhile, cross‐talk with receptors such as EGFR contributes to adaptive resistance during kinase inhibitor treatment. Targeted inhibition—whether by small molecules or neutralizing antibodies—can reverse aberrant FGFR3 signaling, confirming the receptor’s therapeutic potential in both oncologic settings and developmental disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Devendra Singh, Joseph Minhow Chan, Pietro Zoppoli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transforming fusions of FGFR and TACC genes in human glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1220834"}], "href": "https://doi.org/10.1126/science.1220834"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22837387"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22837387"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sarah V Williams, Carolyn D Hurst, Margaret A Knowles "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenic FGFR3 gene fusions in bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/dds486"}], "href": "https://doi.org/10.1093/hmg/dds486"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23175443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23175443"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Brittany C Parker, Matti J Annala, David E Cogdell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI67144"}], "href": "https://doi.org/10.1172/JCI67144"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23298836"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23298836"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jing Qing, Xiangnan Du, Yongmei Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI38017"}], "href": "https://doi.org/10.1172/JCI38017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19381019"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19381019"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Vipin Yadav, Xiaoyi Zhang, Jiangang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.377218"}], "href": "https://doi.org/10.1074/jbc.M112.377218"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22730329"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22730329"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Rui Wang, Lei Wang, Yuan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-14-0284"}], "href": "https://doi.org/10.1158/1078-0432.CCR-14-0284"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24850843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24850843"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "V Chell, K Balmanno, A S Little, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.319"}], "href": "https://doi.org/10.1038/onc.2012.319"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22869148"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22869148"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Maria Teresa Herrera-Abreu, Alex Pearson, James Campbell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Discov (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2159-8290.CD-12-0569"}], "href": "https://doi.org/10.1158/2159-8290.CD-12-0569"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23744832"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23744832"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "D C Tomlinson, O Baldo, P Harnden, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pathol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/path.2207"}], "href": "https://doi.org/10.1002/path.2207"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17668422"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17668422"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Elena López-Knowles, Silvia Hernández, Núria Malats, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-06-1182"}], "href": "https://doi.org/10.1158/0008-5472.CAN-06-1182"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16885334"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16885334"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Bas W G van Rhijn, Theo H van der Kwast, André N Vis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.can-03-2421"}], "href": "https://doi.org/10.1158/0008-5472.can-03-2421"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15026322"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15026322"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "D C Tomlinson, C D Hurst, M A Knowles "}, {"type": "b", "children": [{"type": "t", "text": "Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1210399"}], "href": "https://doi.org/10.1038/sj.onc.1210399"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17384684"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17384684"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "D Lindgren, F Liedberg, A Andersson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1209249"}], "href": "https://doi.org/10.1038/sj.onc.1209249"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16532037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16532037"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Lucie C Kompier, Irene Lurkin, Madelon N M van der Aa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0013821"}], "href": "https://doi.org/10.1371/journal.pone.0013821"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21072204"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21072204"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Karin Birkenkamp-Demtröder, Emil Christensen, Iver Nordentoft, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Urol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.eururo.2017.09.011"}], "href": "https://doi.org/10.1016/j.eururo.2017.09.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28958829"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28958829"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Tahlita C M Zuiverloon, Madelon N M van der Aa, Theo H van der Kwast, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-09-3013"}], "href": "https://doi.org/10.1158/1078-0432.CCR-09-3013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20404005"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20404005"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "James W F Catto, Saiful Miah, Helen C Owen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct microRNA alterations characterize high- and low-grade bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-09-0744"}], "href": "https://doi.org/10.1158/0008-5472.CAN-09-0744"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19843843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19843843"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Silvie Foldynova-Trantirkova, William R Wilcox, Pavel Krejci "}, {"type": "b", "children": [{"type": "t", "text": "Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.21636"}], "href": "https://doi.org/10.1002/humu.21636"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22045636"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22045636"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Madhumita Santra, Fenghuang Zhan, Erming Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2002-09-2801"}], "href": "https://doi.org/10.1182/blood-2002-09-2801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12433679"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12433679"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Christian Hafner, Johanna M M van Oers, Thomas Vogt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI28163"}], "href": "https://doi.org/10.1172/JCI28163"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16841094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16841094"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Anne Goriely, Ruth M S Hansen, Indira B Taylor, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.470"}], "href": "https://doi.org/10.1038/ng.470"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19855393"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19855393"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Suzanne Trudel, A Keith Stewart, Eran Rom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2005-10-4179"}], "href": "https://doi.org/10.1182/blood-2005-10-4179"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16467200"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16467200"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "J Javier Gómez-Román, Pilar Saenz, Miguel Molina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2005)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15701828"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15701828"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Ellen Margrethe Haugsten, Vigdis Sørensen, Andreas Brech, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.02509"}], "href": "https://doi.org/10.1242/jcs.02509"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16091423"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16091423"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Miki Furusho, Yoshimi Kaga, Akihiro Ishii, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.4800-10.2011"}], "href": "https://doi.org/10.1523/JNEUROSCI.4800-10.2011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21451043"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21451043"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Sumin Kang, Shaozhong Dong, Ting-Lei Gu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2007.08.003"}], "href": "https://doi.org/10.1016/j.ccr.2007.08.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17785202"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17785202"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Kathryn E Ware, Marianne E Marshall, Lydia R Heasley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0014117"}], "href": "https://doi.org/10.1371/journal.pone.0014117"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21152424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21152424"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Maria L Henriksson, Sofia Edin, Anna M Dahlin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajpath.2010.12.008"}], "href": "https://doi.org/10.1016/j.ajpath.2010.12.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21356388"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21356388"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Marianne L Seto, Anne V Hing, Jocelyn Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.31630"}], "href": "https://doi.org/10.1002/ajmg.a.31630"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17343269"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17343269"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Takehiko Matsushita, William R Wilcox, Yuk Yu Chan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddn339"}], "href": "https://doi.org/10.1093/hmg/ddn339"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18923003"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18923003"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Keqiang Zhang, Kevin Chu, Xiwei Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-12-2086"}], "href": "https://doi.org/10.1158/0008-5472.CAN-12-2086"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23393200"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23393200"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "C Oneyama, J Ikeda, D Okuzaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.63"}], "href": "https://doi.org/10.1038/onc.2011.63"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21383697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21383697"}]}]}]}
Synonyms ACH, HSFGFR3EX, CEK2, JTK4, CD333
Proteins FGFR3_HUMAN
NCBI Gene ID 2261
API
Download Associations
Predicted Functions View FGFR3's ARCHS4 Predicted Functions.
Co-expressed Genes View FGFR3's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View FGFR3's ARCHS4 Predicted Functions.

Functional Associations

FGFR3 has 17,612 functional associations with biological entities spanning 9 categories (molecular profile, organism, disease, phenotype or trait, chemical, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 131 datasets.

Click the + buttons to view associations for FGFR3 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Achilles Cell Line Gene Essentiality Profiles cell lines with fitness changed by FGFR3 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of FGFR3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of FGFR3 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of FGFR3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of FGFR3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of FGFR3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of FGFR3 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of FGFR3 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of FGFR3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of FGFR3 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of FGFR3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of FGFR3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Gene Mutation Profiles cell lines with FGFR3 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with FGFR3 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of FGFR3 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of FGFR3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of FGFR3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations phenotypes associated with FGFR3 gene from the curated ClinVar Gene-Phenotype Associations dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with FGFR3 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of FGFR3 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing FGFR3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing FGFR3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with FGFR3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with FGFR3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of FGFR3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with FGFR3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with FGFR3 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with FGFR3 gene/protein from the curated CTD Gene-Disease Associations dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by FGFR3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Curated Gene-Disease Association Evidence Scores diseases involving FGFR3 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving FGFR3 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with FGFR3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with FGFR3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with FGFR3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with FGFR3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with FGFR3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for FGFR3 protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at FGFR3 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of FGFR3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of FGFR3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing FGFR3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with FGFR3 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with FGFR3 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of FGFR3 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with FGFR3 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing FGFR3 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of FGFR3 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of FGFR3 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of FGFR3 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of FGFR3 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of FGFR3 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of FGFR3 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving FGFR3 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving FGFR3 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving FGFR3 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing FGFR3 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing FGFR3 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing FGFR3 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by FGFR3 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by FGFR3 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by FGFR3 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of FGFR3 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of FGFR3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of FGFR3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of FGFR3 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
Guide to Pharmacology Chemical Ligands of Receptors ligands (chemical) binding FGFR3 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with FGFR3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of FGFR3 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for FGFR3 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of FGFR3 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of FGFR3 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of FGFR3 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of FGFR3 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with FGFR3 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for FGFR3 from the curated Hub Proteins Protein-Protein Interactions dataset.
HuBMAP ASCT+B Annotations cell types associated with FGFR3 gene from the HuBMAP ASCT+B dataset.
HuBMAP ASCT+B Augmented with RNA-seq Coexpression cell types associated with FGFR3 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with FGFR3 gene from the HuBMAP Azimuth Cell Type Annotations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with FGFR3 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for FGFR3 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of FGFR3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of FGFR3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of FGFR3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate FGFR3 protein from the curated KEA Substrates of Kinases dataset.
KEGG Pathways pathways involving FGFR3 protein from the KEGG Pathways dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of FGFR3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of FGFR3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with FGFR3 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of FGFR3 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS KinomeScan Kinase Inhibitor Targets small molecules inhibiting FGFR3 kinase from the KinomeScan Kinase Inhibitor Targets dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of FGFR3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of FGFR3 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of FGFR3 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing FGFR3 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain FGFR3 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by FGFR3 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting FGFR3 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of FGFR3 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of FGFR3 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by FGFR3 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of FGFR3 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of FGFR3 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing FGFR3 protein recovered by IP-MS from the NURSA Protein Complexes dataset.
OMIM Gene-Disease Associations phenotypes associated with FGFR3 gene from the curated OMIM Gene-Disease Associations dataset.
PANTHER Pathways pathways involving FGFR3 protein from the PANTHER Pathways dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for FGFR3 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of FGFR3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of FGFR3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving FGFR3 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving FGFR3 protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with FGFR3 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
PhosphoSitePlus Substrates of Kinases kinases that phosphorylate FGFR3 protein from the curated PhosphoSitePlus Substrates of Kinases dataset.
Reactome Pathways 2014 pathways involving FGFR3 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving FGFR3 protein from the Reactome Pathways 2024 dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of FGFR3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of FGFR3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at FGFR3 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of FGFR3 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of FGFR3 gene from the RummaGEO Gene Perturbation Signatures dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of FGFR3 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of FGFR3 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of FGFR3 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of FGFR3 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of FGFR3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of FGFR3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of FGFR3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of FGFR3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with FGFR3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with FGFR3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving FGFR3 protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving FGFR3 protein from the WikiPathways Pathways 2024 dataset.